Prognostic effects of 25-hydroxyvitamin D levels in gastric cancer

Journal of Translational Medicine

Volumn 10, Issue 1, 2012, Pages

  Ren, Chao ^a   Qiu, Miao zhen ^a   Wang, De shen ^a   Luo, Hui yan ^a   Zhang, Dong sheng ^a   Wang, Zhi qiang ^a   Wang, Feng hua ^a   Li, Yu hong ^a   Zhou, Zhi wei ^a   Xu, Rui hua ^a  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

Author keywords

Elisa; Gastric cancer; Prognosis; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; 25-HYDROXYVITAMIN D; DRUG DERIVATIVE; VITAMIN D;

ADULT; ARTICLE; BODY MASS; CANCER CLASSIFICATION; CANCER STAGING; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE DURATION; DRINKING BEHAVIOR; FEMALE; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PROGNOSIS; RETROSPECTIVE STUDY; SEASONAL VARIATION; SMOKING; STOMACH CANCER; TUMOR LOCALIZATION; TUMOR VOLUME; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; AGED; BLOOD; CHINA; KAPLAN MEIER METHOD; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; PATHOLOGY; PROPORTIONAL HAZARDS MODEL; STOMACH TUMOR; SURVIVAL RATE;

AGED; CHINA; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; STOMACH NEOPLASMS; SURVIVAL RATE; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84856182082     PISSN: None     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/1479-5876-10-16     Document Type: Article

References (45)

1. Kelley JR, Duggan JM. Gastric cancer epidemiology and risk factors. J Clin Epidemiol 2003, 56:1-9. 10.1016/S0895-4356(02)00534-6, 12589864.
2. Guenter J, Krejs. Gastric cancer: epidemiology and risk factors. Dig Dis 2010, 28:600-603. 10.1159/000320277, 21088409.
3. Deeb KK, Trump DL, Johnson CS. Vitamin D signalling pathways in cancer: potential for anticancer therapeutics. Nat Rev Cancer 2007, 7:684-700. 10.1038/nrc2196, 17721433.
4. DeLuca HF. Overview of general physiologic features and functions of vitamin D. Am J Clin Nutr 2004, 80:1689-1696.
5. Holick MF. Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. Am J Clin Nutr 2004, 80:1678-1688.
6. Fleet JC. Molecular actions of vitamin D contributing to cancer prevention. Mol Aspects Med 2008, 29:388-396. 10.1016/j.mam.2008.07.003, 2613446, 18755215.
7. Hisatake J, O'Kelly J, Uskokovic MR, Tomoyasu S, Koeffler HP. Novel vitamin D(3) analog, 21-(3-methyl-3- hydroxy-butyl)-19-nor D(3), that modulates cell growth, differentiation, apoptosis, cell cycle, and induction of PTEN in leukemic cells. Blood 2001, 97:2427-2433. 10.1182/blood.V97.8.2427, 11290607.
8. Pan L, Matloob AF, Du J, Pan H, Dong Z, Zhao J, et al. Vitamin D stimulates apoptosis in gastric cancer cells in synergy with trichostatin A/sodium butyrate-induced and 5-aza-2'-deoxycytidine-induced PTEN upregulation. FEBS J 2010, 277:989-999. 10.1111/j.1742-4658.2009.07542.x, 20089040.
9. Heaney RP. The vitamin D requirement in health and disease. J Steroid Biochem Mol Biol 2005, 97:13-19. 10.1016/j.jsbmb.2005.06.020, 16026981.
10. IOM report on calcium and vitamin D. 2010, Institute of Medicine, Washington, DC., http://www.iom.edu/vitaminD
11. Zittermann A. Vitamin D in preventive medicine: are we ignoring the evidence?. Br J Nutr 2003, 89:552-572. 10.1079/BJN2003837, 12720576.
12. Gandini S, Boniol M, Haukka J, Byrnes G, Cox B, Sneyd MJ, et al. Meta-analysis of observational studies of serum 25-hydroxyvitamin D levels and colorectal, breast and prostate cancer and colorectal adenoma. Int J Cancer 2011, 128:1414-1424. 10.1002/ijc.25439, 20473927.
13. Giovannucci E. Epidemiology of vitamin D and colorectal cancer: casual or causal link?. J Steroid Biochem Mol Biol 2010, 121:349-354. 10.1016/j.jsbmb.2010.03.085, 20398758.
14. Abnet CC, Chen Y, Chow WH, Gao YT, Helzlsouer KJ, Le Marchand L, et al. Circulating 25-hydroxyvitamin D and risk of esophageal and gastric cancer: cohort consortium Vitamin D pooling project of rarer cancers. Am J Epidemiol 2010, 172:94-106. 10.1093/aje/kwq121, 2892544, 20562192.
15. Giovannucci E, Liu Y, Rimm EB, Hollis BW, Fuchs CS, Stampfer MJ, et al. Prospective study of predictors of vitamin D status and cancer incidence and mortality in men. J Natl Cancer Inst 2006, 98:451-459. 10.1093/jnci/djj101, 16595781.
16. Chen W, Dawsey SM, Qiao YL, Mark SD, Dong ZW, Taylor PR, et al. Prospective study of serum 25(OH)-vitamin D concentration and risk of oesophageal and gastric cancers. Br J Cancer 2007, 97:123-8. 10.1038/sj.bjc.6603834, 2359654, 17551495.
17. Launoy G, Milan C, Day NE, Pienkowski MP, Gignoux M, Faivre J. Diet and squamous-cell cancer of the oesophagus: a French multicentre case-control study. Int J Cancer 1998, 76:7-12. 10.1002/(SICI)1097-0215(19980330)76:1<7::AID-IJC2>3.0.CO;2-4, 9533754.
18. La Vecchia C, Ferraroni M, D'Avanzo B, Decarli A, Franceschi S. Selected micronutrient intake and the risk of gastric cancer. Cancer Epidemiol Biomarkers Prev 1994, 3:393-398.
19. Pelucchi C, Tramacere I, Bertuccio P, Tavani A, Negri E, La Vecchia C. Dietary intake of selected micronutrients and gastric cancer risk: an Italian casecontrol study. Ann Oncol 2009, 20:160-165.
20. Grant WB. An estimate of premature cancer mortality in the US due to inadequate doses of solar ultraviolet-B radiation. Cancer 2002, 94:1867-1875. 10.1002/cncr.10427, 11920550.
21. Giovannucci E, Liu Y, Rimm EB, Hollis BW, Fuchs CS, Stampfer MJ. Prospective study of predictors of vitamin D status and cancer incidence and mortality in men. J Natl Cancer Inst 2006, 98:451-459. 10.1093/jnci/djj101, 16595781.
22. Holick MF. Vitamin D deficiency. N Engl J Med 2007, 357:266-281. 10.1056/NEJMra070553, 17634462.
23. Yao S, Sucheston LE, Millen AE, Johnson CS, Trump DL, Nesline MK, et al. Pretreatment serum concentrations of 25-hydroxyvitamin D and breast cancer prognostic characteristics: a case-control and a case-series study. PLoS One 2011, 6:e17251. 10.1371/journal.pone.0017251, 3046139, 21386992.
24. Napoli N, Vattikuti S, Ma C, Rastelli A, Rayani A, Donepudi R, et al. High prevalence of low vitamin D and musculoskeletal complaints in women with breast cancer. Breast J 2010, 16:609-616. 10.1111/j.1524-4741.2010.01012.x, 21070438.
25. Ng K, Sargent DJ, Goldberg RM, Meyerhardt JA, Green EM, Pitot HC, et al. Vitamin D status in patients with stage IV colorectal cancer: findings from Intergroup trial N9741. J Clin Oncol 2011, 29:1599-1606. 10.1200/JCO.2010.31.7255, 21422438.
26. Looker AC, Pfeiffer CM, Lacher DA, et al. Serum 25- hydroxyvitamin D status of the US population: 1988-1994 compared with 2000-2004. Am J Clin Nutr 2008, 88:1519-1527. 10.3945/ajcn.2008.26182, 2745830, 19064511.
27. Goodwin PJ, Ennis M, Pritchard KI, Schleicher RL, Picciano MF, Yetley EA. Prognostic effects of 25-hydroxyvitamin D levels in early breast cancer. J Clin Oncol 2009, 27:3757-3763. 10.1200/JCO.2008.20.0725, 19451439.
28. Kobayashi T, Okano T, Shida S, et al. Variation of 25-hydroxyvitamin D3 and 25-hydroxyvitamin D2 levels in human plasma obtained from 758 Japanese healthy subjects. J Nutr Sci Vitaminol 1983, 29:271-281. 10.3177/jnsv.29.271, 6604797.
29. Palmieri C, MacGregor T, Girgis S, Vigushin D. Serum 25-hydroxyvitamin D levels in early and advanced breast cancer. J Clin Pathol 2006, 59:1334-1336. 10.1136/jcp.2006.042747, 1860540, 17046848.
30. Neuhouser ML, Sorensen B, Hollis BW, Ambs A, Ulrich CM, McTiernan A, et al. Vitamin D insufficiency in a multiethnic cohort of breast cancer survivors. Am J Clin Nutr 2008, 88:133-139. 2997620, 18614733.
31. Mezawa H, Sugiura T, Watanabe M, et al. Serum vitamin D levels and survival of patients with colorectal cancer: post-hoc analysis of a prospective cohort study. BMC Cancer 2010, 10:347-355. 10.1186/1471-2407-10-347, 2912865, 20594355.
32. Zhou W, Heist RS, Liu G, Asomaning K, Neuberg DS, Hollis BW, et al. Circulating 25-hydroxyvitamin D levels predict survival in early-stage non-small-cell lung cancer patients. J Clin Oncol 2007, 25:479-485. 10.1200/JCO.2006.07.5358, 17290055.
33. Deng J, Liang H, Sun D, Zhang R, Zhan H, Wang X. Prognosis of gastric cancer patients with node-negative metastasis following curative resection: outcomes of the survival and recurrence. Can J Gastroenterol 2008, 22:835-839. 2661304, 18925308.
34. Tuohimaa P, Pukkala E, Scélo G, Olsen JH, Brewster DH, Hemminki K, et al. Does solar exposure, as indicated by the non-melanoma skin cancers, protect from solid cancers: vitamin D as a possible explanation. Eur J Cancer 2007, 43:1701-1712. 10.1016/j.ejca.2007.04.018, 17540555.
35. Grant WB. Lower vitamin-D production from solar ultraviolet-B irradiance may explain some differences in cancer survival rates. J Natl Med Assoc 2006, 98(3):357-364. 2576130, 16573299.
36. Feldman D, Zhao XY, Krishnan AV. Vitamin D and prostate cancer. Endocrinology 2000, 141:5-9. 10.1210/en.141.1.5, 10614617.
37. Holick MF. Vitamin D: importance in the prevention of cancers, type 1 diabetes, heart disease, and osteoporosis. Am J Clin Nutr 2004, 79:362-371.
38. Artaza JN, Norris KC. Vitamin D reduces the expression of collagen and key profibrotic factors by inducing an antifibrotic phenotype in mesenchymal multipotent cells. J Endocrinol 2009, 200:207-221.
39. Matthews D, LaPorta E, Zinser GM, Narvaez CJ, Welsh J. Genomic vitamin D signaling in breast cancer: Insights from animal models and human cells. J Steroid Biochem Mol Biol 2010, 121:362-367. 10.1016/j.jsbmb.2010.03.061, 2906670, 20412854.
40. Kaler P, Augenlicht L, Kampfer L. Macrophage-derived IL-1b stimulates Wnt signaling and growth of colon cancer cells: a crosstalk interrupted by vitamin D3. Oncogene 2009, 28:3892-3902. 10.1038/onc.2009.247, 2783659, 19701245.
41. Cross HS, Kallay E. Regulation of the colonic vitamin D system for prevention of tumor progression: an update. Future Oncol 2009, 5:493-507. 10.2217/fon.09.22, 19450178.
42. Pendas-Franco N, Gonzalez-Sancho JM, Suarez Y, Aguilera O, Steinmeyer A, Gamallo C, et al. Vitamin D regulates the phenotype of human breast cancer cells. Differentiation 2007, 75:193-207. 10.1111/j.1432-0436.2006.00131.x, 17288543.
43. Rino Y, Yamamoto Y, Wada N, Yukawa N, Murakami H, Tamagawa H, et al. Changes in vitamin D after gastrectomy. Gastric Cancer 2007, 10:228-233. 10.1007/s10120-007-0439-2, 18095078.
44. Sharma N, Trope B, Lipman TO. Vitamin supplementation: what the gastroenterologist needs to know. J Clin Gastroenterol 2004, 38:844-854. 10.1097/00004836-200411000-00003, 15492599.
45. Lappe JM, Travers-Gustafson D, Davies KM, Recker RR, Heaney RP. Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial. Am J Clin Nutr 2007, 85:1586-1591.